New insights into NF-κB regulation and function

Trends in Immunology

Volumn 29, Issue 10, 2008, Pages 469-478

  Sun, Shao Cong ^a   Ley, Steven C ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN P100; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 3;

ACETYLATION; APOPTOSIS; CELL NUCLEUS; CYTOPLASM; ENZYME ACTIVATION; GENE ACTIVATION; HUMAN; IMMUNE RESPONSE; IMMUNOSTIMULATION; NONHUMAN; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVIEW; UBIQUITINATION;

ANIMALS; HUMANS; I-KAPPA B KINASE; NF-KAPPA B; NF-KAPPA B P52 SUBUNIT; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED FACTOR 2; TNF RECEPTOR-ASSOCIATED FACTOR 3; TRANSCRIPTION FACTOR RELA; UBIQUITIN-CONJUGATING ENZYMES; UBIQUITINATION;

EID: 52049095036     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.it.2008.07.003     Document Type: Review

References (76)

1. Beinke S., and Ley S.C. Functions of NF-κB1 and NF-κB2 in immune cell biology. Biochem. J. 382 (2004) 393-409
2. Hayden M.S., and Ghosh S. Shared principles in NF-κB signaling. Cell 132 (2008) 344-362
3. Chen Z.J. Ubiquitin signaling in the NF-κB pathway. Nat. Cell Biol. 7 (2005) 758-765
4. Yamamoto M., et al. Key function for the Ubc13 E2 ubiquitin-conjugating enzyme in immune receptor signaling. Nat. Immunol. 7 (2006) 962-970
5. Ni C.Y., et al. K63-linked polyubiquitination of NEMO modulates TLR signaling and inflammation in vivo. J. Immunol. 180 (2008) 7107-7111
6. Fukushima T., et al. Ubiquitin-conjugating enzyme Ubc13 is a critical component of TNF receptor-associated factor (TRAF)-mediated inflammatory responses. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 6371-6376
7. Yamamoto M., et al. Cutting Edge: Pivotal function of Ubc13 in thymocyte TCR signaling. J. Immunol. 177 (2006) 7520-7524
8. Oeckinghaus A., et al. Malt1 ubiquitination triggers NF-kB signaling upon T-cell activation. EMBO J. 26 (2007) 4634-4645
9. Rawlings D.J., et al. The CARMA1 signalosome links the signaling machinery of adaptive and innate immunity in lymphocytes. Nat. Rev. Immunol. 6 (2006) 799-812
10. Wu C.J., and Ashwell J.D. NEMO recognition of ubiquitinated Bcl10 is required for T cell receptor-mediated NF-κB activation. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 3023-3028
11. Shambharkar P.B., et al. Phosphorylation and ubiquitination of the IκB kinase complex by two distinct signaling pathways. EMBO J. 26 (2007) 1794-1805
12. Thiefes A., et al. The Yersinia enterocolitica effector YopP inhibits host cell signaling by inactivating the protein kinase TAK1 in the IL-1 signaling pathway. EMBO Rep. 7 (2006) 838-844
13. Reiley W.W., et al. Deubiquitinating enzyme CYLD negatively regulates the ubiquitin-dependent kinase Tak1 and prevents abnormal T cell responses. J. Exp. Med. 204 (2007) 1475-1485
14. Nijman S.M., et al. A genomic and functional inventory of deubiquitinating enzymes. Cell 123 (2005) 773-786
15. Sun S.C. Deubiquitylation and regulation of the immune response. Nat. Rev. Immunol. 8 (2008) 501-511
16. Massoumi R., et al. CYLD inhibits tumor cell proliferation by blocking bcl-3-dependent NF-κB signaling. Cell 125 (2006) 665-677
17. Beyaert R., et al. A20 and A20-binding proteins as cellular inhibitors of nuclear factor-κB-dependent gene expression and apoptosis. Biochem. Pharmacol. 60 (2000) 1143-1151
18. Lee E.G., et al. Failure to regulate TNF-induced NF-κB and cell death responses in A20-deficient mice. Science 289 (2000) 2350-2354
19. Boone D.L., et al. The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nat. Immunol. 5 (2004) 1052-1060
20. Hitotsumatsu O., et al. The ubiquitin-editing enzyme A20 restricts nucleotide-binding oligomerization domain containing 2-triggered signals. Immunity 28 (2008) 381-390
21. Evans P.C., et al. Zinc-finger protein A20, a regulator of inflammation and cell survival, has de-ubiquitinating activity. Biochem. J. 378 (2004) 727-734
22. Wertz I.E., et al. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signaling. Nature 430 (2004) 694-699
23. Mauro C., et al. ABIN-1 binds to NEMO/IKKγ and co-operates with A20 in inhibiting NF-κB. J. Biol. Chem. 281 (2006) 18482-18488
24. Shembade N., et al. The E3 ligase Itch negatively regulates inflammatory signaling pathways by controlling the function of the ubiquitin-editing enzyme A20. Nat. Immunol. 9 (2008) 254-262
25. Reiley W., et al. Regulation of the deubiquitinating enzyme CYLD by IκB kinase gamma-dependent phosphorylation. Mol. Cell. Biol. 25 (2005) 3886-3895
26. Wright A., et al. Regulation of early wave of germ cell apoptosis and spermatogenesis by deubiquitinating enzyme CYLD. Dev. Cell 13 (2007) 705-716
27. Jin W., et al. Deubiquitinating enzyme CYLD regulates the peripheral development and naive phenotype maintenance of B cells. J. Biol. Chem. 282 (2007) 15884-15893
28. Hövelmeyer N., et al. Regulation of B cell homeostasis and activation by the tumor suppressor gene CYLD. J. Exp. Med. 204 (2007) 2615-2627
29. Hutti J.E., et al. IκB kinase β phosphorylates the K63 deubiquitinase A20 to cause feedback inhibition of the NF-κB pathway. Mol. Cell. Biol. 27 (2007) 7451-7461
30. Zhu G., et al. Optineurin negatively regulates TNFα-induced NF-κB activation by competing with NEMO for ubiquitinated RIP. Curr. Biol. 17 (2007) 1438-1443
31. Wagner S., et al. Ubiquitin binding mediates the NF-κB inhibitory potential of ABINs. Oncogene 27 (2008) 3739-3745
32. Shembade N., et al. Essential role for TAX1BP1 in the termination of TNF-alpha-, IL-1- and LPS-mediated NF-κB and JNK signaling. EMBO J. 26 (2007) 3910-3922
33. Iha H., et al. Inflammatory cardiac valvulitis in TAX1BP1-deficient mice through selective NF-κB activation. EMBO J. 27 (2008) 629-641
34. Jin W., et al. Deubiquitinating enzyme CYLD regulates RANK signaling and osteoclastogenesis. J. Clin. Invest. 118 (2008) 1858-1866
35. Wooten M.W., et al. Essential role of sequestosome 1/p62 in regulating accumulation of Lys63-ubiquitinated proteins. J. Biol. Chem. 283 (2008) 6783-6789
36. Xiao G., et al. NF-κB-inducing kinase regulates the processing of NF-κB2 p100. Mol. Cell 7 (2001) 401-409
37. Senftleben U., et al. Activation of IKKα of a second, evolutionary conserved, NF-κB signaling pathway. Science 293 (2001) 1495-1499
38. Liang C., et al. βTrCP binding and processing of NF-κB2/p100 involve its phosphorylation at serines 866 and 870. Cell. Signal. 18 (2006) 1309-1317
39. Liao G., et al. Regulation of the NF-κB-inducing kinase by tumor necrosis factor receptor-associated factor 3-induced degradation. J. Biol. Chem. 279 (2004) 26243-26250
40. He J.Q., et al. Rescue of TRAF3-null mice by p100 NF-κB deficiency. J. Exp. Med. 203 (2006) 2413-2418
41. Zarnegar B. Control of canonical NF-κB activation through the NIK-IKK complex pathway. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 3503-3508
42. Varfolomeev E., et al. IAP antagonists induce autoubiquitination of c-IAPs, NF-κB activation, and TNFα-dependent apoptosis. Cell 131 (2007) 669-681
43. Vince J.E., et al. IAP antagonists target cIAP1 to induce TNFα-dependent apoptosis. Cell 131 (2007) 682-693
44. Wu H., et al. Smac mimetics and TNFα: a dangerous liaison?. Cell 131 (2007) 655-658
45. Grech A.P., et al. TRAF2 differentially regulates the canonical and noncanonical pathways of NF-κB activation in mature B cells. Immunity 21 (2004) 629-642
46. Moore C.R., and Bishop G.A. Differential regulation of CD40-mediated TNF receptor-associated factor degradation in B lymphocytes. J. Immunol. 175 (2005) 3780-3789
47. Gardam S., et al. TRAF2 and TRAF3 signal adapters act cooperatively to control the maturation and survival signals delivered to B cells by the BAFF receptor. Immunity 28 (2008) 391-401
48. Perkins N.D. Integrating cell-signaling pathways with NF-κB and IKK function. Nat. Rev. Mol. Cell Biol. 8 (2007) 49-62
49. Viatour P., et al. Phosphorylation of NF-κB and IκB proteins: implications in cancer and inflammation. Trends Biochem. Sci. 30 (2005) 43-52
50. Dong J., et al. Repression of gene expression by unphosphorylated NF-κB p65 through epigenetic mechanisms. Genes Dev. 22 (2008) 1159-1173
51. Cheng C.S., et al. Epigenetic control: slow and global, nimble and local. Genes Dev. 22 (2008) 1110-1114
52. Saccani S., et al. Two waves of nuclear factor κB recruitment to target promoters. J. Exp. Med. 193 (2001) 1351-1359
53. Nowak D.E., et al. RelA Ser276 phosphorylation is required for activation of a subset of NF-κB dependent genes by recruiting CDK-9/Cyclin T1 complexes. Mol. Cell. Biol. 28 (2008) 3623-3638
54. Chen L.-F., and Greene W.C. Shaping the nuclear action of NF-κB. Nat. Rev. Mol. Cell Biol. 5 (2004) 392-401
55. Chen L.F., et al. NF-κB RelA phosphorylation regulates RelA acetylation. Mol. Cell. Biol. 25 (2005) 7966-7975
56. Huang W.-C., et al. Phosphorylation of CBP by IKKα promotes cell growth by switching the binding preference of CBP from p53 to NF-κB. Mol. Cell 26 (2007) 75-87
57. Ishinaga H., et al. TGF-β induces p65 acetylation to enhance bacteria-induced NF-κB activation. EMBO J. 26 (2007) 1150-1162
58. Saccani S., et al. Degradation of promoter-bound p65/RelA is essential for the prompt termination of the nuclear factor κB response. J. Exp. Med. 200 (2004) 107-113
59. Ryo A., et al. Regulation of NF-κB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA. Mol. Cell 12 (2003) 1413-1426
60. + lymphocytes. Nature 426 (2003) 853-857
61. Burstein E., et al. COMMD proteins: a novel family of structural and functional homologs of MURR1. J. Biol. Chem. 280 (2005) 22222-22232
62. Maine G.N., et al. COMMD1 promotes the ubiquitination of NF-κB subunits through a cullin-containing ubiquitin ligase. EMBO J. 26 (2007) 436-447
63. Tanaka T., et al. PDLIM2-mediated termination of transcription factor NF-κB activation by intranuclear sequestration and degradation of the p65 subunit. Nat. Immunol. 8 (2007) 584-591
64. Lawrence T., et al. IKKα limits macrophage NF-κB activation and contributes to the resolution of inflammation. Nature 434 (2005) 1138-1143
65. Li Q., et al. Enhanced NF-κB activation and cellular function in macrophages lacking IκB kinase 1 (IKK1). Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 12425-12430
66. Carmody R.J., et al. Negative regulation of toll-like receptor signaling by NF-κB p50 ubiquitination blockade. Science 317 (2007) 675-678
67. Shuai K. Regulation of cytokine signaling pathways by PIAS proteins. Cell Res. 16 (2006) 196-202
68. Liu B., et al. Proinflammatory stimuli induce IKKα-mediated phosphorylation of PIAS1 to restrict inflammation and immunity. Cell 129 (2007) 903-914
69. Wan F., et al. Ribosomal protein S3: a KH domain subunit in NF-κB complexes that mediates selective gene regulation. Cell 131 (2007) 927-939
70. Goto A., et al. Akirins are highly conserved nuclear proteins required for NF-κB-dependent gene expression in drosophila and mice. Nat. Immunol. 9 (2007) 97-104
71. Hoffmann J.A. The immune response of Drosophila. Nature 426 (2003) 33-38
72. Lim C.-A., et al. Genome-wide mapping of RELA(p65) binding identifies E2F1 as a transcriptional activator recruited by NF-κB upon TLR4 activation. Mol. Cell 27 (2007) 622-635
73. Ordureau A., et al. The IRAK-catalysed activation of the E3 ligase function of Pellino isoforms induces the Lys63-linked polyubiquitination of IRAK1. Biochem. J. 409 (2008) 43-52
74. Schauvliege R., et al. Pellino proteins: novel players in TLR and IL-1R signaling. J. Cell. Mol. Med. 11 (2007) 453-461
75. Conze D.B., et al. Lys63-linked polyubiquitination of IRAK-1 is required for interleukin-1 receptor- and toll-like receptor-mediated NF-κB activation. Mol. Cell. Biol. 28 (2008) 3538-3547
76. Windheim M., et al. Interleukin-1 (IL-1) induces the Lys63-linked polyubiquitination of IL-1 receptor-associated kinase 1 to facilitate NEMO binding and the activation of IκB kinase. Mol. Cell. Biol. 28 (2008) 1783-1791